<html><head></head><body><h1>Nystatin Tablets</h1><p class="drug-subtitle"><b>Dosage Form:</b> film coated<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">Rx only</span></p><h2>Nystatin Tablets Description</h2><p class="First">Nystatin is an antimycotic polyene antibiotic obtained from <span class="Italics">Streptomyces noursei</span>. Its structural formula:</p><p>Nystatin Tablets are provided for oral administration as coated tablets containing 500,000 units nystatin.</p><p>Inactive ingredients: anhydrous lactose, carnauba wax, corn starch, D&amp;C Yellow No. 10 Aluminum Lake, FD&amp;C Blue No. 2 Aluminum Lake, FD&amp;C Red No. 40 Aluminum Lake, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, sodium starch glycolate, stearic acid, and titanium dioxide.</p><h2>Nystatin Tablets - Clinical Pharmacology</h2><h3>Pharmacokinetics</h3><p class="First">Gastrointestinal absorption of nystatin is insignificant. Most orally administered nystatin is passed unchanged in the stool. In patients with renal insufficiency receiving oral therapy with conventional dosage forms, significant plasma concentrations of nystatin may occasionally occur.</p><h3>Microbiology</h3><p class="First">Nystatin is both fungistatic and fungicidal <span class="Italics">in vitro</span> against a wide variety of yeasts and yeast-like fungi. <span class="Italics">Candida albicans</span> demonstrates no significant resistance to nystatin <span class="Italics">in vitro</span> on repeated subculture in increasing levels of nystatin; other <span class="Italics">Candida</span> species become quite resistant. Generally, resistance does not develop <span class="Italics">in vivo</span>. Nystatin acts by binding to sterols in the cell membrane of susceptible <span class="Italics">Candida</span> species with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.</p><h2>Indications and Usage for Nystatin Tablets</h2><p class="First">Nystatin Tablets are intended for the treatment of non-esophageal mucus membrane gastrointestinal candidiasis.</p><h2>Contraindications</h2><p class="First">Nystatin Tablets are contraindicated in patients with a history of hypersensitivity to any of their components.</p><h2>Precautions</h2><h3>General</h3><p class="First">This medication is not to be used for the treatment of systemic mycoses. Discontinue treatment if sensitization or irritation is reported during use.</p><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">No long-term animal studies have been performed to evaluate carcinogenic potential. There also have been no studies to determine mutagenicity or whether this medication affects fertility in males or females.</p><h3>Pregnancy</h3><p class="First">Category C</p><p>Animal reproduction studies have not been conducted with nystatin. It is also not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Nystatin should be given to a pregnant woman only if clearly needed.</p><h3>Nursing Mothers</h3><p class="First">It is not known whether nystatin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when nystatin is administered to a nursing woman.</p><h2>Adverse Reactions</h2><p class="First">Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported. (See <span class="Bold">PRECAUTIONS: General.</span>)</p><h3>Gastrointestinal</h3><p class="First">Diarrhea (including one case of bloody diarrhea), nausea, vomiting, gastrointestinal upset/disturbances.</p><h3>Dermatologic</h3><p class="First">Rash, including urticaria has been reported rarely. Stevens-Johnson syndrome has been reported very rarely.</p><h3>Other</h3><p class="First">Tachycardia, bronchospasm, facial swelling, and nonspecific myalgia have also been rarely reported.</p><h2>Overdosage</h2><p class="First">Oral doses of nystatin in excess of five million units daily have caused nausea and gastrointestinal upset. There have been no reports of serious toxic effects of superinfections (see <span class="Bold">CLINICAL PHARMACOLOGY, Pharmacokinetics</span>).</p><h2>Nystatin Tablets Dosage and Administration</h2><p class="First">The usual therapeutic dosage is one to two tablets (500,000 to 1,000,000 units nystatin) three times daily. Treatment should generally be continued for at least 48 hours after clinical cure to prevent relapse.</p><h2>How is Nystatin Tablets Supplied</h2><p class="First">Nystatin Tablets, USP 500,000 units, are round, brown, film coated, debossed MP 83. Available as follows:</p><p class="First">Bottles of 50</p><p class="First">NDC 53489-400-02</p><p class="First">Bottles of 100</p><p class="First">NDC 53489-400-01</p><p class="First">Bottles of 250</p><p class="First">NDC 53489-400-03</p><p class="First">Bottles of 500</p><p class="First">NDC 53489-400-05</p><p class="First">Bottles of 1000</p><p class="First">NDC 53489-400-10</p><p class="First">Store at 20° to 25°C (68° to 77°F).</p><p>[See USP Controlled Room Temperature]</p><p>DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER.</p><p class="First">Distributed by:<br/>
<span class="Bold">Sun Pharmaceutical Industries, Inc.</span><br/>
Cranbury, NJ 08512</p><p>Rev 02, November 2014</p><h2>PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label</h2><p class="First"><span class="Bold">NystatinTablets USP (oral)- 100 tablets</span></p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Can triamcinolone acetonide B be used to treat severe diaper rash on a little girl?</li>
</ul><h2>More about nystatin</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>64 Reviews</li>
<li>Drug class: mouth and throat products</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nystatin &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Nystatin Oral Suspension &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Nystatin Vaginal Insert &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Gastrointestinal Candidiasis</li>
<li>Oral Thrush</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>